Cathinone is a monoamine alkaloid found in the shrub Catha edulis (Khat). Closely related to ephedrine, cathine and other amphetamines, it is probably the main contributor to the stimulant effect of Catha edulis. Cathinone differs from many other amphetamines in that its structure is a ketone. Other amphetamines to share this structure include the antidepressant bupropion and the stimulant methcathinone, among others. Internationally, cathinone is categorized as a Schedule I drug. Cathinone was added to the Controlled Substances Act's Schedule I in 1993 in compliance with international laws.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Cathinone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Cathinone. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Cathinone. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cathinone. |
| Hydrocodone | Cathinone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cathinone. |
| Magnesium sulfate | The therapeutic efficacy of Cathinone can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Cathinone may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Cathinone may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Cathinone. |
| Mirtazapine | Cathinone may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Cathinone. |
| Orphenadrine | Cathinone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Cathinone may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Cathinone. |
| Pramipexole | Cathinone may increase the sedative activities of Pramipexole. |
| Ropinirole | Cathinone may increase the sedative activities of Ropinirole. |
| Rotigotine | Cathinone may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Cathinone. |
| Sodium oxybate | Cathinone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Cathinone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Cathinone. |
| Thalidomide | Cathinone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Cathinone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Cathinone. |
| Ethanol | Cathinone may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Cathinone may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Cathinone. |
| Zimelidine | The risk or severity of adverse effects can be increased when Cathinone is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Cathinone is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Cathinone is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Cathinone is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Cathinone is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Cathinone is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Cathinone is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Cathinone is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Cathinone is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Cathinone is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Cathinone is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Cathinone is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Cathinone is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Cathinone is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Cathinone is combined with Levomilnacipran. |
| Indalpine | The risk or severity of adverse effects can be increased when Cathinone is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Cathinone is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Cathinone is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Cathinone. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Cathinone. |
| Zopiclone | The risk or severity of adverse effects can be increased when Cathinone is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Cathinone. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Cathinone. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cathinone. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Cathinone. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Cathinone. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Cathinone. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Cathinone. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Cathinone. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Cathinone. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Cathinone. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Cathinone. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Cathinone. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Cathinone. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Cathinone. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Cathinone. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Cathinone. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Cathinone. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Cathinone. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Cathinone. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Cathinone. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Cathinone. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Cathinone. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Cathinone. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Cathinone. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Cathinone. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Cathinone. |
| Thiethylperazine | The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Cathinone. |
| Palonosetron | The risk or severity of CNS depression can be increased when Palonosetron is combined with Cathinone. |
| Dexbrompheniramine | The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Cathinone. |
| Metocurine iodide | The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Cathinone. |
| Secobarbital | The risk or severity of CNS depression can be increased when Secobarbital is combined with Cathinone. |
| Methocarbamol | The risk or severity of CNS depression can be increased when Methocarbamol is combined with Cathinone. |
| Triprolidine | The risk or severity of CNS depression can be increased when Triprolidine is combined with Cathinone. |
| Meperidine | The risk or severity of CNS depression can be increased when Meperidine is combined with Cathinone. |
| Metharbital | The risk or severity of CNS depression can be increased when Metharbital is combined with Cathinone. |
| Quinine | The risk or severity of CNS depression can be increased when Quinine is combined with Cathinone. |
| Methohexital | The risk or severity of CNS depression can be increased when Methohexital is combined with Cathinone. |
| Gallamine triethiodide | The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Cathinone. |
| Entacapone | The risk or severity of CNS depression can be increased when Entacapone is combined with Cathinone. |
| Oxycodone | The risk or severity of CNS depression can be increased when Oxycodone is combined with Cathinone. |
| Dextromethorphan | The risk or severity of CNS depression can be increased when Dextromethorphan is combined with Cathinone. |
| Mephenytoin | The risk or severity of CNS depression can be increased when Mephenytoin is combined with Cathinone. |
| Cisatracurium | The risk or severity of CNS depression can be increased when Cisatracurium is combined with Cathinone. |
| Fenfluramine | The risk or severity of CNS depression can be increased when Fenfluramine is combined with Cathinone. |
| Mazindol | The risk or severity of CNS depression can be increased when Mazindol is combined with Cathinone. |
| Fluticasone propionate | The risk or severity of CNS depression can be increased when Fluticasone propionate is combined with Cathinone. |
| Lisuride | The risk or severity of CNS depression can be increased when Lisuride is combined with Cathinone. |
| Ethosuximide | The risk or severity of CNS depression can be increased when Ethosuximide is combined with Cathinone. |
| Thiopental | The risk or severity of CNS depression can be increased when Thiopental is combined with Cathinone. |
| Cisapride | The risk or severity of CNS depression can be increased when Cisapride is combined with Cathinone. |
| Butorphanol | The risk or severity of CNS depression can be increased when Butorphanol is combined with Cathinone. |